LEADER 01465nam  2200373Ka 450 
001 9910695813003321
005 20070620133945.0
035   $a(CKB)5470000002373665
035   $a(OCoLC)144670528
035   $a(EXLCZ)995470000002373665
100   $a20070620d2007      ua         0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe emergence of India's pharmaceutical industry and implications for the U.S. generic drug market$b[electronic resource] /$fWilliam Greene
210  1$a[Washington, D.C.] :$cU.S. International Trade Commission, Office of Economics,$d[2007]
215   $aiv, 36 pages $cdigital, PDF file
225 1 $aOffice of Economics working paper ;$vno. 2007-05-A
300   $aTitle from title screen (viewed on June 20, 2007).
300   $a"May 2007."
320   $aIncludes bibliographical references.
606   $aPharmaceutical industry$zIndia
607   $aIndia$xForeign economic relations$zUnited States
607   $aUnited States$xForeign economic relations$zIndia
615  0$aPharmaceutical industry
700   $aGreene$b William L$01407590
712 02$aUnited States International Trade Commission.$bOffice of Economics.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695813003321
996   $aThe emergence of India's pharmaceutical industry and implications for the U.S. generic drug market$93547311
997   $aUNINA